Molecular Features of the Serrated Pathway to Colorectal Cancer: Current Knowledge and Future Directions

Area of Science:

• Colorectal Cancer Research
• Molecular Carcinogenesis
• Gastroenterology

Background:

• Serrated lesions represent a distinct precursor to colorectal cancer, accounting for up to 30% of cases.
• The serrated pathway involves complex molecular alterations including MAPK pathway changes, CpG island methylation, and microsatellite instability.
• Existing research on serrated pathway mechanisms is fragmented, hindering clinical risk assessment.

Purpose of the Study:

• To review and synthesize current literature on the molecular mechanisms of serrated lesions and serrated pathway colorectal cancer.
• To identify knowledge gaps and areas requiring further investigation in serrated carcinogenesis.
• To propose a unified model of serrated carcinogenesis and discuss future research directions.

Main Methods:

• Comprehensive literature review of studies on serrated lesions and colorectal cancer molecular pathways.
• Analysis of molecular alterations including MAPK, CpG island methylation, microsatellite instability, WNT activation, and microRNA dysregulation.
• Synthesis of findings to propose a unified serrated carcinogenesis pathway model.

Main Results:

• Detailed description of molecular mechanisms underlying different serrated lesions and colorectal cancer phenotypes.
• Identification of key molecular processes: MAPK pathway alterations, CpG island methylation phenotype, and microsatellite instability.
• Proposal of a unified model integrating molecular events and lesion types in serrated carcinogenesis.

Conclusions:

• Clarifying the molecular underpinnings of serrated lesions is essential for accurate clinical risk stratification.
• Further research is needed to address inconsistencies in methodologies and definitions within the field.
• Advancing understanding of the serrated pathway can lead to novel prevention strategies and therapeutic targets for colorectal cancer.